The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Ozempic Novo Nordisk Pharmaceuticals Pty Ltd
Product name
Ozempic
Accepted date
Sep-2024
Active ingredients
Semaglutide
Proposed indication
To reduce the risk of kidney failure.
Application type
C (new indication)
Publication date
Sep-2024